The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Oct. 24, 2023

Filed:

Oct. 07, 2020
Applicants:

The Broad Institute, Inc., Cambridge, MA (US);

Massachusetts Institute of Technology, Cambridge, MA (US);

The Brigham and Women's Hospital, Inc., Boston, MA (US);

Inventors:

Ana Carrizosa Anderson, Boston, MA (US);

Asaf Madi, Boston, MA (US);

Nandini Acharya, Boston, MA (US);

Vijay K. Kuchroo, Boston, MA (US);

Aviv Regev, Cambridge, MA (US);

Assignees:
Attorneys:
Primary Examiner:
Int. Cl.
CPC ...
A61K 31/4015 (2006.01); C12N 15/113 (2010.01); C12N 9/10 (2006.01); C07K 16/28 (2006.01); A61K 9/00 (2006.01);
U.S. Cl.
CPC ...
A61K 31/4015 (2013.01); C12N 9/10 (2013.01); C12N 15/113 (2013.01); A61K 9/0019 (2013.01); C07K 16/2818 (2013.01); C07K 16/2827 (2013.01); C12N 2310/20 (2017.05);
Abstract

The subject matter disclosed herein is generally directed to modulating anti-tumor T cell immunity by modulating steroidogenesis. Steroidogenesis may be modulated with inhibitors of enzymes that synthesize glucocorticoids in a tumor. The inhibitor may target Cyp11a1. The inhibitor may be metyrapone. The invention further relates to modulating immune states, such as CD8 T cell immune states, in vivo, ex vivo and in vitro. The invention further relates to diagnostic and screening methods.


Find Patent Forward Citations

Loading…